ATE293127T1
Synthetic peptide inhibitors of hiv transmission
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 7 June 2014, 12.3 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
80 members in 16 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 7302893 | United States of America | A | |
| 9405739 | United States of America | W |
Members80
| Document | Office | Kind | |
|---|---|---|---|
| CA2164698A1 | Canada | A1 | |
| WO9428920A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7042694A | Australia | A | |
| US5464933A | United States of America | A | |
| KR960702753A | Republic of Korea | A | |
| CA2208420A1 | Canada | A1 | |
| WO9619495A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4473496A | Australia | A | |
| JPH08511525A | Japan | A | |
| EP0774971A1 | European Patent Office (EPO) | A1 | |
| EP0793675A1 | European Patent Office (EPO) | A1 | |
| KR987000333A | Republic of Korea | A | |
| EP0774971A4 | European Patent Office (EPO) | A4 | |
| AU692777B2 | Australia | B2 | |
| EP0793675A4 | European Patent Office (EPO) | A4 | |
| NZ267803A | New Zealand | A | |
| AU714695B2 | Australia | B2 | |
| US6013263A | United States of America | A | |
| US6017536A | United States of America | A | |
| NZ300002A | New Zealand | A | |
| US6054265A | United States of America | A | |
| US6060065A | United States of America | A | |
| NZ329775A | New Zealand | A | |
| US6068973A | United States of America | A | |
| US6093794A | United States of America | A | |
| US6133418A | United States of America | A | |
| US6228983B1 | United States of America | B1 | |
| JP2001523082A | Japan | A | |
| US6333395B1 | United States of America | B1 | |
| NZ501727A | New Zealand | A | |
| US6440656B1 | United States of America | B1 | |
| US6479055B1 | United States of America | B1 | |
| KR100355407B1 | Republic of Korea | B1 | |
| US6518013B1 | United States of America | B1 | |
| US2004033235A1 | United States of America | A1 | |
| US2004052820A1 | United States of America | A1 | |
| US6824783B1 | United States of America | B1 | |
| EP0774971B1 | European Patent Office (EPO) | B1 | |
| AT293127T | Austria | T | |
| ATE293127T1This record | Austria | T1 | |
| DE69434335D1 | Germany | D1 | |
| CL2004001413A1 | Chile | A1 | |
| LU91166I2 | Luxembourg | I2 | |
| NL300192I1 | Netherlands (Kingdom of the) | I1 | |
| PT774971E | Portugal | E | |
| NL300192I2 | Netherlands (Kingdom of the) | I2 | |
| DE122005000025I1 | Germany | I1 | |
| DK0774971T3 | Denmark | T3 | |
| ES2238674T3 | Spain | T3 | |
| US6951717B1 | United States of America | B1 | |
| EP0793675B1 | European Patent Office (EPO) | B1 | |
| AT308558T | Austria | T | |
| ATE308558T1 | Austria | T1 | |
| EP1595890A2 | European Patent Office (EPO) | A2 | |
| DE69534569D1 | Germany | D1 | |
| DE122005000025I2 | Germany | I2 | |
| DE69434335T2 | Germany | T2 | |
| ES2252747T3 | Spain | T3 | |
| JP2006176529A | Japan | A | |
| DE69534569T2 | Germany | T2 | |
| US7122190B2 | United States of America | B2 | |
| EP1714974A2 | European Patent Office (EPO) | A2 | |
| KR100558087B1 | Republic of Korea | B1 | |
| US2007037141A1 | United States of America | A1 | |
| EP1595890A3 | European Patent Office (EPO) | A3 | |
| EP1714974A3 | European Patent Office (EPO) | A3 | |
| EP0793675B9 | European Patent Office (EPO) | B9 | |
| US2007202123A1 | United States of America | A1 | |
| US2007202127A1 | United States of America | A1 | |
| US7273614B2 | United States of America | B2 | |
| JP4205159B2 | Japan | B2 | |
| US7514397B1 | United States of America | B1 | |
| JP2009213475A | Japan | A | |
| CL2009002139A1 | Chile | A1 | |
| US7794725B1 | United States of America | B1 | |
| CA2208420C | Canada | C | |
| US2010291680A1 | United States of America | A1 | |
| US7988974B2 | United States of America | B2 | |
| US2011275146A1 | United States of America | A1 | |
| CA2164698C | Canada | C |
Numbers
- Application
- 94919201
Titles2
- German
- SYNTHETISCHE PEPTIDINHIBITOREN DER HIV- ÜBERTRAGUNG
- English
- SYNTHETIC PEPTIDE INHIBITORS OF HIV TRANSMISSION
Classification
- CPC, 35
- A61K38/00
- C07K14/005
- A61K39/00
- A61K2039/525
- C07K5/0806
- C07K5/0808
- C07K5/0812
- C07K5/0815
- C07K5/0817
- C07K5/0819
- C07K5/1008
- C07K5/101
- C07K5/1013
- C07K5/1016
- C07K5/1021
- C07K5/1024
- C07K14/21
- C07K14/22
- C07K14/285
- C07K14/31
- C12N2710/16222
- C12N2730/10122
- C12N2740/15022
- C12N2740/16122
- C12N2740/16222
- C12N2760/16122
- C12N2760/18022
- C12N2760/18122
- C12N2760/18422
- C12N2760/18522
- Y10S435/974
- Y10S530/826
- A61P31/12
- C07K14/16
- A61K38/12
- IPC, 41
- G01N33 566
- A61K38 00
- A61K38 16
- A61K39 00
- A61K39 12
- A61P31 12
- C07K5 083
- C07K5 087
- C07K5 09
- C07K5 093
- C07K5 103
- C07K5 107
- C07K5 113
- C07K5 117
- C07K7 06
- C07K7 08
- C07K14 005
- C07K14 02
- C07K14 05
- C07K14 11
- C07K14 115
- C07K14 12
- C07K14 125
- C07K14 13
- C07K14 135
- C07K14 15
- C07K14 155
- C07K14 16
- C07K14 21
- C07K14 22
- C07K14 285
- C07K14 31
- C07K17 08
- C07K17 10
- C12N15 11
- C12N15 62
- C12N15 63
- C12Q1 00
- C12Q1 70
- G01N33 53
- G01N33 569